Drug
Qeq278
Qeq278: highest development phase Phase 1, developed by Novartis. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Novartis
Trials
| Drug | Phase | Indication |
|---|---|---|
| QEQ278 NCT05462873 | Phase 1 | Carcinoma, Non-Small-Cell Lung |
Latest
No recent events.
Follow Qeq278 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.